Feasibility of an Integrated Medical Care Program for Patients With Continuing Health Complaints After Amalgam Removal (IMCR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02081664|
Recruitment Status : Completed
First Posted : March 7, 2014
Last Update Posted : June 10, 2015
Some patients report relief of symptoms after amalgam removal. However, a large group of patients are still suffering from partly severe health complaints even after the removal of amalgam. To date, no biological/medical explanation for these Amalgam attributed health complaints is available.
The objective of this study is to develop an integrated medical care rehabilitation program and determine if it is a valid and feasible treatment for patients with persistent symptoms after amalgam removal. Such a comprehensive concept has to date not been operationalized in Norway, but information about the feasibility and the challenges around such a rehabilitation program are required, in order to prepare for a possible controlled and randomized study evaluating the effects of the suggested integrative care treatment program. This treatment program will focus on "learning by practicing", hence the study participants will be enrolled into a group program focusing on life-style changes. In addition to the life-style oriented group program, an individualized treatment strategy with therapies out of the spectrum of Complementary and Alternative Medicine (CAM) will be part of the treatment program. This part of the program is based on the results of a survey, related to use of CAM therapies, conducted in 2012 among the members of the patient organization "Forbundet Tenner og Helse".
Participants of this treatment program must amongst other inclusion criteria have removed all dental amalgam fillings and experience symptoms which have not disappeared after removal of the dental fillings. Specific exclusion criteria are stated. The group program consists of 12 sessions which are held once per week for a whole day. Added to this is a choice of CAM therapies from a hierarchic list, established from the survey, and which accordingly is based on risk/benefit judgment. Data collection will take place at baseline, after 12 weeks (end of treatment), and three month later. The aim of this study is to test the feasibility of an integrated medical care rehabilitation program for patients in Norway who have had their Amalgam fillings removed, but still suffer from Amalgam attributed symptoms. It combines a lifestyle oriented group program with individualized CAM therapies in form of an outpatient program.
|Condition or disease||Intervention/treatment||Phase|
|Health Complaints Attributed to Previous Amalgam Fillings||Behavioral: lifestyle intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||21 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Development and Feasibility Assessment of an Integrated Medical Care Rehabilitation Program for Patients With Continuing Health Complaints After Amalgam Removal - The IMCR Trial|
|Study Start Date :||January 2014|
|Actual Primary Completion Date :||October 2014|
|Actual Study Completion Date :||October 2014|
life-style oriented group program together with an individualized treatment program using therapies out of the spectrum of Complementary and Alternative Medicine (CAM)
Behavioral: lifestyle intervention
- achieved patient enrollment rates (number of patients eligible) [ Time Frame: 8 weeks ]number of patients who are willing to participate and are eligible
- MYMOP (scale from 0 to 6) [ Time Frame: difference between baseline and 3 months ]MYMOP is a patient-generated instrument where patients themselves decide what their most relevant health complaint is.
- MYMOP (scale from 0 to 6) [ Time Frame: difference between baseline and 6 months ]MYMOP is a patient-generated instrument where patients themselves decide what their most relevant health complaint is.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02081664
|University of Tromsø|
|Tromsø, Troms, Norway, 9037|
|Principal Investigator:||Frauke Musial, PhD||University of Tromso|